Home
>
Chemical Reagents>Impurities>Heterocycles>
>
1-[(2'-Carbamoylbiphenyl-4-yl) methyl]-2-ethoxybenzimidazole-7-carboxylic Acid
For research use only. Not for therapeutic Use.
1-[(2′-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic Acid (CAT: C000614), also known as Degadant-3, is an intermediate compound used in the synthesis of azilsartan kamedoxomil, which is an angiotensin II receptor blocker. Azilsartan kamedoxomil is used in the treatment of hypertension and related cardiovascular conditions. Degadant-3 plays a crucial role in the preparation of azilsartan kamedoxomil, contributing to the synthesis of this medication.
Catalog Number | C000614 |
CAS Number | 1696392-11-6 |
Synonyms | 1-[[2′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic Acid |
Molecular Formula | C₂₄H₂₁N₃O₄ |
Purity | ≥95% |
Solubility | Aqueous Base (Slightly), DMSO (Slightly) |
Appearance | White to Off-White Solid |
Storage | 4°C |
Reference | Garaga, S., et al.: Org. Process Res. Dev., 19, 514 (2015); Sethi, M. K., et al.: Pharma Chemica, 7, 20 (2015) |